Form D · Other Health Care

NEOGENOMICS INC

Ft. Myers, FL · CIK 0001077183

Offering snapshot reported Mar 30, 2009 · SEC filing

Reported sold
$500K
Offering amount: $1.16M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 30, 2009Initial$500,000No comparisonNot reportedSEC filing
Jun 14, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-51319

Source: Form D, filed Mar 30, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael T. Dent Director
Jerome J. Dvonch Executive
Robert J. Feeney Executive
Robert P. Gasparini Director, Executive
Marvin E. Jaffe Director
Steven C. Jones Director, Executive
Matthew William Moore Executive
George G. O'leary Director
Peter M. Peterson Director
William J. Robison Director
Douglas M. Van Oort Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
12701 Commonwealth Drive, Suite 9
Ft. Myers, FL, 33913